TY - JOUR
T1 - Brain Fog in Hypothyroidism
T2 - Understanding the Patient's Perspective
AU - Ettleson, Matthew D.
AU - Raine, Ava
AU - Batistuzzo, Alice
AU - Batista, Samuel P.
AU - McAninch, Elizabeth
AU - Teixeira, Maria Cristina T.V.
AU - Jonklaas, Jacqueline
AU - Laiteerapong, Neda
AU - Ribeiro, Miriam O.
AU - Bianco, Antonio C.
N1 - Publisher Copyright:
© 2021 AACE
PY - 2022/3
Y1 - 2022/3
N2 - Objective: Patient-centered studies have shown that several patients on thyroid hormone replacement therapy for hypothyroidism exhibit persistent symptoms, including “brain fog.” Here, we aimed to determine which of these specific symptoms are associated with brain fog, identify patient-reported factors that modify these symptoms, and identify patient concerns related to brain fog not included in thyroid-specific questionnaires. Methods: A survey on brain fog symptoms adapted from thyroid-specific patient-reported outcome was distributed online. Textual data analysis was performed to identify common areas of concern from open-ended survey responses. Results: A total of 5170 participants reporting brain fog while being treated for hypothyroidism were included in the analysis. Of these, 2409 (46.6%) participants reported symptom onset prior to the diagnosis of hypothyroidism, and 4096 (79.2%) participants experienced brain fog symptoms frequently. Of the symptoms listed, participants associated fatigue and forgetfulness most frequently with brain fog. More rest was the most common factor provided for improving symptoms. The textual data analysis identified areas of concern that are not often included in thyroid-specific quality of life questionnaires, including a focus on the diagnosis of hypothyroidism, the types and doses of medications, and the patient-doctor relationship. Conclusion: Brain fog in patients treated for hypothyroidism was associated most frequently with fatigue and cognitive symptoms. Several additional areas of patient concern were found to be associated with brain fog, which are not typically addressed in thyroid-specific questionnaires.
AB - Objective: Patient-centered studies have shown that several patients on thyroid hormone replacement therapy for hypothyroidism exhibit persistent symptoms, including “brain fog.” Here, we aimed to determine which of these specific symptoms are associated with brain fog, identify patient-reported factors that modify these symptoms, and identify patient concerns related to brain fog not included in thyroid-specific questionnaires. Methods: A survey on brain fog symptoms adapted from thyroid-specific patient-reported outcome was distributed online. Textual data analysis was performed to identify common areas of concern from open-ended survey responses. Results: A total of 5170 participants reporting brain fog while being treated for hypothyroidism were included in the analysis. Of these, 2409 (46.6%) participants reported symptom onset prior to the diagnosis of hypothyroidism, and 4096 (79.2%) participants experienced brain fog symptoms frequently. Of the symptoms listed, participants associated fatigue and forgetfulness most frequently with brain fog. More rest was the most common factor provided for improving symptoms. The textual data analysis identified areas of concern that are not often included in thyroid-specific quality of life questionnaires, including a focus on the diagnosis of hypothyroidism, the types and doses of medications, and the patient-doctor relationship. Conclusion: Brain fog in patients treated for hypothyroidism was associated most frequently with fatigue and cognitive symptoms. Several additional areas of patient concern were found to be associated with brain fog, which are not typically addressed in thyroid-specific questionnaires.
KW - brain fog
KW - fatigue
KW - hypothyroidism
KW - memory
UR - http://www.scopus.com/inward/record.url?scp=85121836703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121836703&partnerID=8YFLogxK
U2 - 10.1016/j.eprac.2021.12.003
DO - 10.1016/j.eprac.2021.12.003
M3 - Article
C2 - 34890786
AN - SCOPUS:85121836703
SN - 1530-891X
VL - 28
SP - 257
EP - 264
JO - Endocrine Practice
JF - Endocrine Practice
IS - 3
ER -